Quinn Opportunity Partners LLC Increases Holdings in Tilray Inc (NASDAQ:TLRY)

Quinn Opportunity Partners LLC lifted its stake in shares of Tilray Inc (NASDAQ:TLRY - Free Report) by 108.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,618,080 shares of the company's stock after buying an additional 840,000 shares during the period. Quinn Opportunity Partners LLC owned about 0.17% of Tilray worth $2,152,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Newman Dignan & Sheerar Inc. increased its holdings in Tilray by 61.9% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares during the period. KBC Group NV increased its position in Tilray by 75.9% during the 4th quarter. KBC Group NV now owns 38,332 shares of the company's stock valued at $51,000 after purchasing an additional 16,539 shares during the period. Jones Financial Companies Lllp raised its stake in Tilray by 125.7% during the fourth quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company's stock worth $42,000 after buying an additional 17,670 shares during the last quarter. Pallas Capital Advisors LLC raised its holdings in shares of Tilray by 59.4% during the fourth quarter. Pallas Capital Advisors LLC now owns 50,438 shares of the company's stock valued at $67,000 after purchasing an additional 18,792 shares during the period. Finally, Madrona Financial Services LLC raised its position in shares of Tilray by 40.0% during the fourth quarter. Madrona Financial Services LLC now owns 70,000 shares of the company's stock worth $93,000 after purchasing an additional 20,000 shares during the period. 9.35% of the stock is currently owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Canaccord Genuity Group raised their price objective on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Piper Sandler dropped their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th.

Tilray Stock Down 2.9 %

NASDAQ TLRY traded down $0.01 on Tuesday, reaching $0.47. The company had a trading volume of 19,714,279 shares, compared to its average volume of 29,423,245. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The company's fifty day moving average is $0.71 and its 200 day moving average is $1.16. Tilray Inc has a 52-week low of $0.44 and a 52-week high of $2.52. The stock has a market capitalization of $443.32 million, a P/E ratio of -1.58 and a beta of 1.88.

Tilray (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $185.78 million during the quarter, compared to analysts' expectations of $213.38 million. Sell-side analysts anticipate that Tilray Inc will post -0.2 earnings per share for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.